In vitro diagnostics account for only about 2% of total healthcare spending yet influence over 66% of clinical decision-making

More than 75% of the 7 lakh annual cancer deaths in India can be prevented with early screening and diagnosis

Remote monitoring can reduce Hospitalisations and deaths in heart failure patients by 29% and 20% respectively

Studies have shown that India’s health system has a persistent challenge of limited resources – including cost of care, accessible quality care, trained professionals, and lag in uptake of effective technology solutions. Limited personnel and infrastructure constraints cause long turnaround times for diagnosis and initiation of treatment contributing to the rising disease burden, out of pocket expenditures and worsening health conditions. The window for early interventions is missed, which is critical for prevention and management of most of the chronic illnesses.


Pfizer INDovation: NIPERs Edition, with Social Alpha, Pfizer and NIPERs as anchor partners is designed to support start-ups building high-quality affordable diagnostics. The NIPERs will offer their lab infrastructure and technical expertise for product development. Social Alpha as the anchor partner for INDovation, will curate the innovations and support venture development for the selected cohort.

The program is for early-stage innovations to complete product development, user surveys and pre-clinical testing. Pfizer, Social Alpha, and partner NIPERs will collectively enable the accelerator and support the innovators to build contextual solutions to improve the healthcare system in India.

Focus Areas

Who Should Apply

The program aims to support the progression of six healthtech start-ups (with a working proof of concept demonstrated) that are building innovative solutions to make high-quality diagnostics accessible.

Program Offerings

The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring. The start-ups will receive a grant amount of up to INR 25 lakhs and acceleration support from Social Alpha and NIPERs towards:
Assistance in Product Development: Access to NIPERs’ prototyping labs/infrastructure, funds, and technical mentorship
Advisory for Design for Manufacturing: Guidance on optimising the product design by NIPERs’ technical experts
Tech Transfer Support from NIPERs: Explore collaboration opportunities for tech transfer with academia etc. through NIPERs ecosystem
Advisory on Regulatory Roadmap Planning: Guidance from Social Alpha to align various regulatory and quality documents in line with statutory and international standards requirements
Pre-Clinical Studies with Partner Hospitals: Access to Social Alpha’s ecosystem for demonstration of safety and working of the solution in lab-settings (controlled and non-interventional
Customer Discovery and Market Identification: Engagement with stakeholders (Tertiary care, Community Health Organisations, NGOs) part of Social Alpha’s network to validate problem statements, clinical fitment, and user experience

Important Dates

  • Applications Open

    October 9th, 2023
  • Deadline for Applications

    November 6th, 2023
  • Evaluation of Applications

    End of November, 2023
  • Jury Round

    December 4th and 5th, 2023
  • Announcement of Winners

    December 8th, 2023
  • Induction and Launch of the Accelerator

    Mid December, 2023
  • Incubation for 12 months

    January 2024 to December 2024

Our Partners

frequently asked questions
Terms and Conditions

For any assistance needed in filling the application form, please reach out to us at